» Articles » PMID: 24047275

Leukocyte Infiltration in Experimental Stroke

Overview
Publisher Biomed Central
Date 2013 Sep 20
PMID 24047275
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

Stroke is one of the leading causes of death worldwide. At present, the only available treatment is thrombolysis, which should be initiated no later than 4.5 hours after onset of symptoms. Several studies have shown that an attenuation of the inflammatory response in relation to stroke could widen the therapeutic window. However, the immune system has important functions following infarction, such as removal of dead cells and the subsequent astrocytosis as well as prevention of post-ischemic infection. Hence, detailed knowledge concerning the temporal profile of leukocyte infiltration is necessary in order to develop new and effective treatments.The purpose of this review is to determine the temporal profile of leukocyte (neutrophil granulocytes, macrophages and T-cells) infiltration following experimental stroke. We found that the number of neutrophil granulocytes peaks between day 1 and 3 after experimental stroke, with short occlusion times (30 and 60 minutes of middle cerebral artery occlusion (MCAO)) leading to a later peak in response (P <0.001). Macrophages/microglia were found to peak later than day 3 and stay in the infarcted area for longer time periods, whereas duration of occlusion had no influence on the temporal infiltration (P = 0.475). Studies on T-cell infiltration are few; however, a tendency towards infiltration peak at later time points (from day 4 onwards) was seen.This review provides a framework for the instigation of post-stroke anti-inflammatory treatment, which could prove beneficial and widen the therapeutic window compared to current treatment options.

Citing Articles

Phosphodiesterase 4 inhibition as a novel treatment for stroke.

Zhong J, Yu X, Lin Z PeerJ. 2025; 13:e18905.

PMID: 39897494 PMC: 11786714. DOI: 10.7717/peerj.18905.


The Role of Endothelial L-PGDS in the Pro-Angiogenic and Anti-Inflammatory Effects of Low-Dose Alcohol Consumption.

Li J, Li C, Subedi U, Subedi P, Panchatcharam M, Sun H Cells. 2024; 13(23).

PMID: 39682755 PMC: 11640003. DOI: 10.3390/cells13232007.


Increased peripheral leukocyte aggravates brain injury and leads to poor outcome in stroke patients receiving intravenous thrombolysis: A study based on clinical evidence.

Zhang K, Qu Y, Abuduxukuer R, Zhang P, Zhang Y, Gao J J Cereb Blood Flow Metab. 2024; 45(3):396-404.

PMID: 39235536 PMC: 11574925. DOI: 10.1177/0271678X241281020.


Mechanisms of inflammation after ischemic stroke in brain-peripheral crosstalk.

Xie L, He M, Ying C, Chu H Front Mol Neurosci. 2024; 17:1400808.

PMID: 38932932 PMC: 11199882. DOI: 10.3389/fnmol.2024.1400808.


Activation of Inflammasomes and Relevant Modulators for the Treatment of Microglia-mediated Neuroinflammation in Ischemic Stroke.

Zeng Z, Lin X, Yang L, Li Y, Gao W Mol Neurobiol. 2024; 61(12):10792-10804.

PMID: 38789893 DOI: 10.1007/s12035-024-04225-1.


References
1.
Kleinschnitz C, Schwab N, Kraft P, Hagedorn I, Dreykluft A, Schwarz T . Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. Blood. 2010; 115(18):3835-42. DOI: 10.1182/blood-2009-10-249078. View

2.
Matsuo Y, Kihara T, Ikeda M, Ninomiya M, Onodera H, Kogure K . Role of neutrophils in radical production during ischemia and reperfusion of the rat brain: effect of neutrophil depletion on extracellular ascorbyl radical formation. J Cereb Blood Flow Metab. 1995; 15(6):941-7. DOI: 10.1038/jcbfm.1995.119. View

3.
Brait V, Arumugam T, Drummond G, Sobey C . Importance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia. J Cereb Blood Flow Metab. 2012; 32(4):598-611. PMC: 3318155. DOI: 10.1038/jcbfm.2012.6. View

4.
Li G, Zhong D, Yang L, Sun B, Zhong Z, Yin Y . Expression of interleukin-17 in ischemic brain tissue. Scand J Immunol. 2005; 62(5):481-6. DOI: 10.1111/j.1365-3083.2005.01683.x. View

5.
Sarchielli P, Nardi K, Chiasserini D, Eusebi P, Tantucci M, Di Piero V . Immunological profile of silent brain infarction and lacunar stroke. PLoS One. 2013; 8(7):e68428. PMC: 3706426. DOI: 10.1371/journal.pone.0068428. View